• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溴隐亭无法抑制产后正常孕妇促甲状腺激素释放激素刺激的β-内啡肽/β-促脂解素及皮质醇的分泌。

Bromocriptine is unable to suppress TRH-stimulated beta-endorphin/beta-lipotropin and cortisol secretion in normal pregnant women after delivery.

作者信息

Lamberts S W, Angement R, van der Heijden A, Wladimiroff J W, Hackeng W H, de Jong F H

机构信息

Department of Medicine, Erasmus University, Rotterdam, The Netherlands.

出版信息

Horm Res. 1987;27(4):195-9. doi: 10.1159/000180819.

DOI:10.1159/000180819
PMID:2963790
Abstract

The course of plasma beta-endorphin/beta-lipotropin, cortisol and prolactin (PRL) levels was followed from 0.5 till 5 h after normal delivery in 13 healthy women. Six subjects who did not want to breast-feed their child received 2.5 mg bromocriptine orally 1 h after delivery. After 3 h the effect of the intravenous administration of 200 micrograms thyrotropin-releasing hormone (TRH) was also measured. Elevated plasma beta-endorphin and cortisol levels decreased after delivery in a (log) linear fashion which was not influenced by bromocriptine. TRH elicited a significant short-lived identical increase in plasma beta-endorphin/beta-lipotropin concentrations in the control and the bromocriptine-treated subjects. TRH similarly delayed the rapid decline in plasma cortisol levels in both groups of women. Basal and TRH-induced PRL levels were rapidly suppressed by bromocriptine. These studies show the presence of a paradoxical increase of beta-endorphin/beta-lipotropin and cortisol levels in response to TRH occurring shortly after delivery in normal women. This response cannot be mediated by the placenta. The absence of an inhibiting effect of bromocriptine on basal and TRH-induced beta-endorphin and cortisol release does not lend support to the hypothesis of the presence of a functionally active intermediate pituitary lobe in man early in puerperium.

摘要

对13名健康女性正常分娩后0.5至5小时内血浆β-内啡肽/β-促脂素、皮质醇和催乳素(PRL)水平的变化过程进行了跟踪研究。6名不想母乳喂养孩子的受试者在分娩后1小时口服2.5毫克溴隐亭。3小时后,还测量了静脉注射200微克促甲状腺激素释放激素(TRH)的效果。分娩后,血浆β-内啡肽和皮质醇水平升高呈(对数)线性下降,不受溴隐亭影响。TRH在对照组和溴隐亭治疗组受试者中引起血浆β-内啡肽/β-促脂素浓度显著且短暂的相同升高。TRH同样延迟了两组女性血浆皮质醇水平的快速下降。溴隐亭迅速抑制了基础和TRH诱导的PRL水平。这些研究表明,正常女性分娩后不久,TRH会引起β-内啡肽/β-促脂素和皮质醇水平出现矛盾性升高。这种反应不能由胎盘介导。溴隐亭对基础和TRH诱导的β-内啡肽和皮质醇释放没有抑制作用,这并不支持产后早期人体存在功能活跃的垂体中叶这一假说。

相似文献

1
Bromocriptine is unable to suppress TRH-stimulated beta-endorphin/beta-lipotropin and cortisol secretion in normal pregnant women after delivery.溴隐亭无法抑制产后正常孕妇促甲状腺激素释放激素刺激的β-内啡肽/β-促脂解素及皮质醇的分泌。
Horm Res. 1987;27(4):195-9. doi: 10.1159/000180819.
2
Does bromocriptine block thyrotropin-releasing hormone-induced prolactin release during pregnancy?
J Clin Endocrinol Metab. 1980 Mar;50(3):600-2. doi: 10.1210/jcem-50-3-600.
3
Bromocriptine suppression of TRH-stimulated prolactin and thyrotrophin release and accompanying inhibition of bromocriptine induced growth hormone release by TRH in normal man.溴隐亭对正常男性促甲状腺激素释放激素(TRH)刺激的催乳素和促甲状腺素释放的抑制作用以及TRH对溴隐亭诱导的生长激素释放的伴随抑制作用。
Clin Endocrinol (Oxf). 1979 May;10(5):481-8. doi: 10.1111/j.1365-2265.1979.tb02104.x.
4
Infusion of beta-endorphin has no suppressive effect on the releasing hormone-stimulated pituitary-adrenal-axis of normal human subjects.注入β-内啡肽对正常人体受试者中释放激素刺激的垂体-肾上腺轴没有抑制作用。
Acta Endocrinol (Copenh). 1990 Nov;123(5):526-30. doi: 10.1530/acta.0.1230526.
5
Puerperal breast feeding does not stimulate circulating opioids in humans.产后母乳喂养不会刺激人体循环中的阿片类物质。
J Endocrinol Invest. 1982 Nov-Dec;5(6):367-71. doi: 10.1007/BF03350534.
6
Abnormal beta-endorphin and beta-lipotropin responses to TRH and LRH administration in primary and secondary affective disorders.原发性和继发性情感障碍患者对促甲状腺激素释放激素(TRH)和促黄体生成素释放激素(LRH)给药的β-内啡肽和β-促脂素反应异常。
Acta Endocrinol (Copenh). 1986 Aug;112(4):481-6. doi: 10.1530/acta.0.1120481.
7
Hyperprolactinemia exerts a negative effect on the beta-endorphin content of the rat neurointermediate pituitary lobe.高催乳素血症对大鼠神经垂体中间叶的β-内啡肽含量产生负面影响。
Endocrinology. 1984 Jun;114(6):2349-53. doi: 10.1210/endo-114-6-2349.
8
[Study on the neuroendocrinological control of prolactin release in early puerperium].[产褥早期催乳素释放的神经内分泌调控研究]
Nihon Sanka Fujinka Gakkai Zasshi. 1987 Jul;39(7):1108-14.
9
Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.肢端肥大症患者中,纯生长激素(GH)垂体腺瘤和生长激素/催乳素混合垂体腺瘤对胍法辛、溴隐亭和促甲状腺激素释放激素的生长激素分泌反应不同。
J Clin Endocrinol Metab. 1985 Jun;60(6):1148-53. doi: 10.1210/jcem-60-6-1148.
10
Adrenocorticotropin and cortisol responsiveness to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone discloses two subsets of patients with Cushing's disease.促肾上腺皮质激素和皮质醇对促甲状腺激素释放激素和促黄体生成素释放激素的反应性揭示了库欣病患者的两个亚组。
J Clin Endocrinol Metab. 1982 Dec;55(6):1188-97. doi: 10.1210/jcem-55-6-1188.